跳至主要内容
临床试验/EUCTR2017-004297-34-GB
EUCTR2017-004297-34-GB进行中(未招募)1 期

A placebo controlled double blind randomised controlled proof of concept study of zolpidem for the treatment of motor and cognitive deficits in late-stage Parkinson’s - Zolpidem for treatment of motor and cognitive deficits in Parkinson's

Aston University0 个研究点目标入组 28 人开始时间: 2018年6月22日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Diagnosis of idiopathic Parkinson’s and Hoehn and Yahr score of 2.5 or more.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 14
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 14

排除标准

  • Under the age of 40 years.
  • Over the age of 80 years.
  • Unable or unwilling to give informed consent
  • Current therapy with CNS depressants
  • Current therapy with CPY450 (CYP3A4) inhibitors or inducers
  • History of psychiatric disorders
  • History of alcohol or substance abuse
  • Employed in a role that involves driving or operating heavy machinery
  • Participating in another interventional clinical trial

研究者

相似试验

se of low-dose zolpidem in Parkinson's. | 临床试验